Tempus AI, Inc. (NASDAQ:TEM) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the thirteen ratings firms that are currently covering the stock, MarketBeat reports. Six investment analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 12 month price objective among brokers that have covered the stock in the last year is $63.42.

Several research analysts have issued reports on the company. BTIG Research began coverage on Tempus AI in a report on Monday, April 21st. They issued a "buy" rating and a $60.00 price target on the stock. William Blair reiterated a "market perform" rating on shares of Tempus AI in a research report on Tuesday, February 25th. Needham & Company LLC reiterated a "buy" rating and set a $70.00 price objective on shares of Tempus AI in a research report on Wednesday, May 7th. Wolfe Research cut shares of Tempus AI from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, February 26th. Finally, Piper Sandler lifted their price objective on shares of Tempus AI from $55.00 to $70.00 and gave the stock a "neutral" rating in a research report on Thursday, May 15th.

Tempus AI Price Performance

Shares of NASDAQ:TEM opened at $65.65 on Tuesday. Tempus AI has a 12 month low of $22.89 and a 12 month high of $91.45. The stock has a market cap of $11.37 billion and a price-to-earnings ratio of -8.42. The stock's 50 day moving average price is $59.18 and its 200 day moving average price is $52.81. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.71 and a quick ratio of 1.56.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.27) by $0.03. The company had revenue of $255.74 million for the quarter, compared to analysts' expectations of $248.13 million. Tempus AI had a negative return on equity of 533.21% and a negative net margin of 88.27%. The business's quarterly revenue was up 75.4% compared to the same quarter last year. Equities research analysts anticipate that Tempus AI will post -6.15 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Tempus AI news, EVP Erik Phelps sold 51,317 shares of the business's stock in a transaction on Monday, June 16th. The shares were sold at an average price of $72.56, for a total transaction of $3,723,561.52. Following the completion of the transaction, the executive vice president now owns 97,779 shares of the company's stock, valued at $7,094,844.24. The trade was a 34.42% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Andrew Polovin sold 17,552 shares of the company's stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $63.43, for a total transaction of $1,113,323.36. Following the transaction, the executive vice president now directly owns 138,877 shares of the company's stock, valued at $8,808,968.11. This represents a 11.22% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 609,897 shares of company stock valued at $41,397,783 in the last quarter. Insiders own 27.60% of the company's stock.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Vanguard Group Inc. increased its stake in Tempus AI by 6,247.5% in the first quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company's stock valued at $289,204,000 after acquiring an additional 5,900,668 shares during the period. ARK Investment Management LLC increased its stake in Tempus AI by 132.1% in the fourth quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company's stock valued at $186,343,000 after acquiring an additional 3,141,487 shares during the period. Nikko Asset Management Americas Inc. increased its stake in Tempus AI by 166.0% in the fourth quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company's stock valued at $109,352,000 after acquiring an additional 2,021,394 shares during the period. Franklin Resources Inc. increased its stake in Tempus AI by 240.5% in the fourth quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company's stock valued at $93,251,000 after acquiring an additional 1,950,862 shares during the period. Finally, JPMorgan Chase & Co. increased its stake in Tempus AI by 86,947.2% in the fourth quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company's stock valued at $55,836,000 after acquiring an additional 1,651,996 shares during the period. Institutional investors and hedge funds own 24.22% of the company's stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.